Perez-Gomez, M.V.; Sanchez-Niño, M.D.; Sanz, A.B.; Martín-Cleary, C.; Ruiz-Ortega, M.; Egido, J.; Navarro-González, J.F.; Ortiz, A.; Fernandez-Fernandez, B.
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade. J. Clin. Med. 2015, 4, 1325-1347.
https://doi.org/10.3390/jcm4061325
AMA Style
Perez-Gomez MV, Sanchez-Niño MD, Sanz AB, Martín-Cleary C, Ruiz-Ortega M, Egido J, Navarro-González JF, Ortiz A, Fernandez-Fernandez B.
Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade. Journal of Clinical Medicine. 2015; 4(6):1325-1347.
https://doi.org/10.3390/jcm4061325
Chicago/Turabian Style
Perez-Gomez, Maria Vanessa, Maria Dolores Sanchez-Niño, Ana Belen Sanz, Catalina Martín-Cleary, Marta Ruiz-Ortega, Jesus Egido, Juan F. Navarro-González, Alberto Ortiz, and Beatriz Fernandez-Fernandez.
2015. "Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade" Journal of Clinical Medicine 4, no. 6: 1325-1347.
https://doi.org/10.3390/jcm4061325
APA Style
Perez-Gomez, M. V., Sanchez-Niño, M. D., Sanz, A. B., Martín-Cleary, C., Ruiz-Ortega, M., Egido, J., Navarro-González, J. F., Ortiz, A., & Fernandez-Fernandez, B.
(2015). Horizon 2020 in Diabetic Kidney Disease: The Clinical Trial Pipeline for Add-On Therapies on Top of Renin Angiotensin System Blockade. Journal of Clinical Medicine, 4(6), 1325-1347.
https://doi.org/10.3390/jcm4061325